Last reviewed · How we verify

NCT04379063: COPING

COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress

Completed Last updated 20 December 2022
What this trial tests

trial testing COVID-19 pandemic in Burnout, Professional in 342 participants. Completed in 18 July 2022.

Timeline
13 May 2020
Primary endpoint
28 September 2020
18 July 2022

Quick facts

Lead sponsorJon Bailey
StatusCompleted
Study typeOBSERVATIONAL
Enrollment342
Start date13 May 2020
Primary completion28 September 2020
Estimated completion18 July 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Jon Bailey

Who can join

Eligibility, any sex, with Burnout, Professional or Psychological Distress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Coronavirus Disease (COVID-19) pandemic is unprecedented in its scale of infection and the response required to decrease the mortality rates. Disturbingly, the European and United States experience demonstrates that health care systems in industrialized countries are at risk of becoming overwhelmed. Physicians are already at risk of burnout under normal working conditions, and in particular, when responding to crisis situations. During the 2003 severe acute respiratory syndrome (SARS) outbreak, healthcare workers experienced high rates of psychological distress that lasted years. However, there may be protective factors that may decrease the rate or severity of psychological distress and burnout. This study seeks to investigate the rates of physician burnout assessed at multiple time points during the COVID-19 pandemic. Further, this study seeks to determine the factors that may increase or decrease burnout and psychological distress in such a setting. This study will be a national longitudinal survey of physicians in Canada. It will include all physicians that currently hold a license to practice in Canada (whether in training or a full license). Consenting participants will complete an initial survey gathering information about their type of practice, health conditions, preparations the COVID-19 pandemic, burnout, and psychological distress. Every month, participants will be asked to complete a follow-up survey, describing their stressors, coping strategies, burnout, and psychological distress. The investigators will analyze and report the initial results to help provincial and national organizations support our physicians and mitigate burnout during this pandemic. The results of the follow up surveys will be analyzed and reported following the pandemic. These findings will help keep our physician workforce healthy under normal working conditions and during future crises.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
    Pollock A, Campbell P, Cheyne J, Cowie J, et al · · 2020 · cited 412× · PMID 33150970 · DOI 10.1002/14651858.cd013779
  2. Pandemic-related factors predicting physician burnout beyond established organizational factors: cross-sectional results from the COPING survey.
    Bailey JG, Wong M, Bailey K, Banfield JC, et al · · 2023 · cited 7× · PMID 34649468 · DOI 10.1080/13548506.2021.1990366

Verify or expand the search:

Other trials of COVID-19 pandemic

Trials testing the same drug.

Other recruiting trials for Burnout, Professional

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04379063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing